Clinical Trial Update: A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease [Phase 3]

View source ↗

Summary

A Phase 3 study comparing torcetrapib/atorvastatin vs atorvastatin alone in patients with coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Torcetrapib/atorvastatin (torcetrapib; atorvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Coronary Disease, Diabetes Mellitus | Phase 3 | Status: TERMINATED